Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons
- 20 September 2016
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 32 (12) , 2039-2046
Abstract
The objective of this study was to investigate changes in health-related quality of life (HRQOL) among HIV patients following switch from a first- to second-line antiretroviral therapy (ART) regimen. This was an observational study of adult HIV patients in the US at 35 academic and community health centers. Patients were required to be switching an antiretroviral regimen for the first time at the enrollment visit. Patients were assigned to a study cohort based on whether the switch was due to treatment-related side effects or for any other reason as reported by their physician. Patients completed the Medical Outcomes Study-Human Immunodeficiency Virus (MOS-HIV) health survey, the Depression, Anxiety, and Stress Scale Short Form (DASS-21), and the Human Immunodeficiency Virus Treatment Satisfaction Questionnaire-status (HIVTSQs) at the enrollment visit (baseline) and a follow-up survey was completed approximately 4 weeks later. The within cohort change in survey measures from baseline to follow-up was assessed by two-sample paired t-test. Patients who switched their ART regimen due to treatment-related side effects (n = 50) had statistically significant improvements (p < .05, baseline to follow-up) in mean Physical and Mental Health Summary scores (MOS-HIV scale) and in all three HIVTSQ summary scores. Patients who switched for other reasons (n = 44) did not experience statistically significant improvements in these same measures. HIV patients whose regimen was switched due to treatment-related side effects experienced an improvement in QOL following the switch. Physicians should take the potential impact on QOL into consideration when deciding on a switch in ART regimen, particularly when patients are intolerant of their current treatment. The results are based on a patient survey and may have been influenced by recall and response bias.Keywords
This publication has 31 references indexed in Scilit:
- Antiretroviral Treatment of Adult HIV InfectionJAMA, 2014
- Cost of Treatment in a US Commercially Insured, HIV-1–Infected PopulationPLOS ONE, 2014
- Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAIDS, 2013
- The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysisAIDS Care, 2012
- Antiretroviral therapy adherence and drug–drug interactions in the aging HIV populationAIDS, 2012
- Doctor-patient concordance during HIV treatment switching decision-makingHIV Medicine, 2010
- Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapineAIDS Care, 2009
- Strategies for Improving Patient Adherence to Therapy and Long-Term Patient OutcomesJournal of the Association of Nurses in AIDS Care, 2007
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998